Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BlueBioTech is a German biotechnology company specializing in the cultivation and processing of microalgae for the nutraceutical, cosmetic, and pharmaceutical industries. The company develops and operates advanced photobioreactors to produce high-quality biomass and bioactive compounds such as astaxanthin and omega-3 fatty acids. In addition to product manufacturing, BlueBioTech provides research and development services, focusing on strain selection, process optimization, and the extraction of valuable marine substances. Their expertise spans from laboratory-scale development to industrial-scale production, positioning them as a key player in the blue biotechnology sector. The company also offers contract manufacturing services for specialized algae-based products, leveraging their proprietary cultivation technologies. BlueBioTech's products are utilized globally in health supplements and functional foods, emphasizing sustainable and high-purity production methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BlueBioTech Int.